Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00261612
Status:
UNKNOWN
Last Update Posted:
2006-10-18
First Post:
2005-12-01
Brief Title:
Bortezomib Rituximab and Dexamethasone BORID for RelapsedRefractory Mantle Cell Lymphoma
Sponsor:
Medical University of Vienna
Organization:
Medical University of Vienna
Organization Data
Organization:
Medical University of Vienna
Class:
OTHER
Study ID:
2004-002150-64
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Medical University of Vienna
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None